论文部分内容阅读
目的:观察中晚期原发性肝癌经肝动脉化疗栓塞术治疗的疗效及不良反应。方法:65例中晚期原发性肝癌患者,接受TACE治疗,评估疗效和不良反应。结果:经治疗后38.4%(25/65)的患者部分缓解:58.4%(38/65)病情稳定:生存期明显延长,1、2、3年生存率分别为46.1%(30/65)、21.5%(14/65)、7.6%(5/65)。结论:TACE是治疗中晚期肝癌的有效方法,明显提高生存期。
Objective: To observe the curative effect and side effects of transcatheter arterial chemoembolization in the treatment of advanced primary liver cancer. Methods: Sixty-five patients with advanced primary hepatocellular carcinoma were treated with TACE to evaluate the efficacy and adverse reactions. Results: After treatment, 38.4% (25/65) patients were partially relieved: 58.4% (38/65) had stable disease: the survival time was significantly longer, and the 1-, 2-, 3- year survival rates were 46.1% (30/65) 21.5% (14/65), 7.6% (5/65). Conclusion: TACE is an effective method for the treatment of advanced hepatocellular carcinoma and significantly improves the survival time.